SCHEMBL13754207

SCHEMBL13754207

Cc1nc(S(C)(=O)=O)nc(C)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 2/20 0.35
TP53 P04637 2/20 0.35
MAPK1 P28482 2/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TLR9 Q9NR96 2/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
SDHB P21912 4/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GLP1R P43220 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7754111 0.88 LMNA (0.38) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL7753498 0.86 SMN1; SMN2 (0.36) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL6250177 0.84 LMNA (0.35) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL11509596 0.84 GLP1R (0.38) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL11509593 0.84 LMNA (0.35) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL9432620 0.81 SMN1; SMN2 (0.47) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL25859859 0.79 SMN1; SMN2 (0.41) LMNASMN1; SMN2ALDH1A1TP53MAPK1
SCHEMBL9625868 0.78 LMNA (0.38) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL10647312 0.78 LMNA (0.44) LMNASMN1; SMN2CA12CA2CA9
SCHEMBL10123082 0.77 LMNA (0.40) LMNASMN1; SMN2CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209743-A1 COLOURED ORGANOPOLYSILOXANES DYSTAR COLOURS DEUTSCHLAND GMBH (DE) 2009-08-20 US disclosed
US-20070149719-A1 Granular polysaccharide polymer having phthalocyanine skeleton bonded thereto SHOWA DENKO K.K. (JP) 2007-06-28 US disclosed
US-20070149719-A1 Granular polysaccharide polymer having phthalocyanine skeleton bonded thereto SHOWA DENKO K.K. (JP) 2007-06-28 US disclosed
US-20070106033-A1 Crosslinked polymer having phthalocyanine bonded thereto SHOWA DENKO K.K. (JP) 2007-05-10 US disclosed
US-20070106033-A1 Crosslinked polymer having phthalocyanine bonded thereto SHOWA DENKO K.K. (JP) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209743-A1 COLOURED ORGANOPOLYSILOXANES MSR1, ARSA, HBS1L LMNA 1297/4885SMN1; SMN2 315/4885CA12 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.